Edges in Network
| Network | GSE5851_egf1520 - GSE5851 - SiGN-BN HC+Bootstrap |
| Network Description | Phase II exploratory pharmacogenomics study of cetuximab monotherapy in patients with advanced metastatic CRC |
| Node | SMAD2 |
| Upstream (Parents) |
|---|
| (<<) BCL2A1 → SMAD2 |
| (<<) CASP3 → SMAD2 |
| (<<) CXCR7 → SMAD2 |
| (<<) ENO3 → SMAD2 |
| (<<) ITGAE → SMAD2 |
| (<<) KCNK1 → SMAD2 |
| (<<) LTA4H → SMAD2 |
| (<<) MLXIPL → SMAD2 |
| (<<) PPP3CA → SMAD2 |
| (<<) RPS6KB1 → SMAD2 |
| (<<) SOCS6 → SMAD2 |
| (<<) TAF1A → SMAD2 |
| (<<) UBE2D3 → SMAD2 |
| Downstream (Children) |
|---|
| SMAD2 → ARAF (>>) |
| SMAD2 → CBL (>>) |
| SMAD2 → FER1L4 (>>) |
| SMAD2 → GLS (>>) |
| SMAD2 → MAP3K11 (>>) |
| SMAD2 → NPC1 (>>) |
| SMAD2 → PCSK1N (>>) |
| SMAD2 → RBM7 (>>) |
| SMAD2 → RNF138 (>>) |
| SMAD2 → RPA4 (>>) |
| SMAD2 → SCG5 (>>) |
| SMAD2 → SMAD7 (>>) |
| SMAD2 → STAM2 (>>) |
| SMAD2 → TMEM158 (>>) |
| SMAD2 → TNFAIP3 (>>) |
| SMAD2 → WNT4 (>>) |
